Relay Therapeutics, Inc. (RLAY)
18.18
-0.16
(-0.87%)
USD |
NASDAQ |
Oct 23, 16:00
18.18
0.00 (0.00%)
After-Hours: 20:00
Relay Therapeutics Market Cap : 3.973B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.973B |
| October 22, 2026 | 4.008B |
| October 21, 2026 | 4.023B |
| October 20, 2026 | 4.032B |
| October 19, 2026 | 3.735B |
| October 16, 2026 | 3.558B |
| October 15, 2026 | 3.781B |
| October 14, 2026 | 3.728B |
| October 13, 2026 | 3.794B |
| October 12, 2026 | 3.929B |
| October 09, 2026 | 3.907B |
| October 08, 2026 | 3.805B |
| October 07, 2026 | 3.923B |
| October 06, 2026 | 4.095B |
| October 05, 2026 | 4.237B |
| October 02, 2026 | 4.143B |
| October 01, 2026 | 4.041B |
| September 30, 2026 | 3.944B |
| September 29, 2026 | 4.012B |
| September 28, 2026 | 3.866B |
| September 25, 2026 | 3.818B |
| September 24, 2026 | 3.875B |
| September 23, 2026 | 3.940B |
| September 22, 2026 | 4.229B |
| September 21, 2026 | 3.975B |
| Date | Value |
|---|---|
| September 18, 2026 | 4.117B |
| September 17, 2026 | 4.194B |
| September 16, 2026 | 4.117B |
| September 15, 2026 | 4.146B |
| September 14, 2026 | 4.165B |
| September 11, 2026 | 4.124B |
| September 10, 2026 | 4.128B |
| September 09, 2026 | 4.078B |
| September 08, 2026 | 4.176B |
| September 04, 2026 | 4.161B |
| September 03, 2026 | 4.154B |
| September 02, 2026 | 4.045B |
| September 01, 2026 | 4.041B |
| August 31, 2026 | 4.017B |
| August 28, 2026 | 4.102B |
| August 27, 2026 | 4.244B |
| August 26, 2026 | 4.253B |
| August 25, 2026 | 4.495B |
| August 24, 2026 | 4.318B |
| August 21, 2026 | 4.248B |
| August 20, 2026 | 4.305B |
| August 19, 2026 | 4.532B |
| August 18, 2026 | 4.504B |
| August 17, 2026 | 4.517B |
| August 14, 2026 | 4.340B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 2.330B |
| TG Therapeutics, Inc. | 8.292B |
| Karyopharm Therapeutics, Inc. | 11.74M |
| Spyre Therapeutics, Inc. | 7.955B |
| Akebia Therapeutics, Inc. | 154.05M |
Market Cap Related Metrics
| PS Ratio | 319.90 |
| Price to Book Value | 4.464 |
| Price | 18.18 |
| Earnings Yield | -8.62% |